thymoquinone has been researched along with gemcitabine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, S; Kaseb, AO; Kong, D; Mohammad, M; Mohammad, RM; Padhye, S; Sarkar, FH; Wang, Z | 1 |
Azmi, AS; Banerjee, S; Baruah, JB; Mohammad, RM; Padhye, S; Philip, PA; Sarkar, FH; Singh, MW | 1 |
Bamezai, RN; Kumar, B; Manvati, S; Pandita, A; Singh, SK; Vaishnavi, S | 1 |
Li, HY; Liao, Y; Mu, GG; Yu, HG; Zhang, LL | 1 |
Bamezai, RN; Manvati, S; Pandita, A; Singh, SK; Vaishnavi, S | 1 |
5 other study(ies) available for thymoquinone and gemcitabine
Article | Year |
---|---|
Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Cytochromes c; Deoxycytidine; Dinoprostone; Drug Synergism; Female; Gemcitabine; Humans; Mice; Mice, Inbred ICR; Mice, SCID; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms | 2009 |
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Deoxycytidine; Gemcitabine; Humans; Mice; Mice, SCID; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Prostaglandins E; Structure-Activity Relationship | 2010 |
Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Betulinic Acid; Carrier Proteins; Cell Proliferation; Deoxycytidine; Drug Synergism; Flow Cytometry; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Membrane Potential, Mitochondrial; Membrane Proteins; Pancreatic Neoplasms; Pentacyclic Triterpenes; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Triterpenes; Tumor Cells, Cultured | 2014 |
Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Mice, Inbred BALB C; Mice, Nude; Nigella sativa; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Receptor, Notch1; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2015 |
Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Benzoquinones; Betulinic Acid; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dietary Supplements; Drug Synergism; Gemcitabine; Humans; MicroRNAs; Pancreas; Pancreatic Neoplasms; Pentacyclic Triterpenes; Transfection; Triterpenes | 2015 |